• Clinical Trials - Prostate cancer

    Study Objective Contact
    A Registry of Sipuleucel-T Therapy in Men with Advanced Prostate Cancer The purpose(s) of this registry study is to learn more about the occurrence of cerebrovascular events (more commonly known as “strokes”) reported during or following sipuleucel-T therapy, to learn about the survival of all study subjects, to understand the order and timing of anticancer therapies you may receive following treatment with sipuleucel-T, and to look at changes in your prostate specific antigen (PSA) levels following treatment with sipuleucel-T and other anticancer therapies. Principal Investigator(s):
    Christopher G. Tretter, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Nevin Bhardwaj.
    Development of "Tissue Print" Techniques for the Analysis of Prostate Needle Biopsies Molecular analysis of tissue samples to research diagnostic, prognostic and therapeutic advancements. Principal Investigator(s):
    Kimberly R. Christ, PhD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Doreen L. Browne, ,CCRP,
    Linda M. Topjian.
    Molecular Analysis of Cancer The purpose of this research is to discover molecular changes involved in cancer. We hope that a better understanding of these changes can improve cancer management. This research may include genetic and/or genomic analysis (tests to determine and compare your genetic sequence, or DNA). Some of the tissue we collect for our research may be submitted to the National Cancer Institute Cancer Genome Atlas Project. The goal of this project is to determine the genomic changes involved in more than 20 types of human cancer. Principal Investigator(s):
    Kimberly R. Christ, PhD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Doreen L. Browne, ,CCRP,
    Jane S. Nalwalk,
    Linda M. Topjian.